Skip to Content
Morningstar AustraliaMorningstar Australia
Market Centre
Market Report
Market Calendar
Discover Investments
Read the latest investing news and insights
Industry Insights
Investing content
Learn to invest in...
How to invest
Our research
Our Solutions
Featured Products and Services
The Company

EyeGene Inc

185490

Company Profile

  • Business description

    EyeGene Inc is a South Korea based bio-venture company. It researches and develops biopharmaceuticals. Its products include EG-Mirotin, EG-HPV, EGVac systems. It provides drugs for the treatment of age-related degenerative diseases. Its products target diabetic retinopathy.

  • Contact

    Gangseo-gu, Seoul 401
    B-dong 910 Gayang-dong
    Seoul07528
    KOR

    T: +82 23221687

    http://www.eyegene.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    49

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,660.3022.500.26%
CAC 407,805.2425.520.33%
DAX 4024,127.39194.160.81%
Dow JONES (US)42,215.73117.030.28%
FTSE 1008,775.2058.750.67%
HKSE23,289.77283.61-1.20%
NASDAQ19,175.8774.930.39%
Nikkei 22537,965.10467.88-1.22%
NZX 50 Index12,418.89137.581.12%
S&P 5005,912.1723.620.40%
S&P/ASX 2008,434.7024.900.30%
SSE Composite Index3,347.4915.96-0.47%

Market Movers